Translate :

Maryland Department of Health

CovidCONNECT

Clinical Studies

Why Clinical Studies Are Important

Clinical research is essential to the development of new medications, new treatments, and new vaccines especially in a novel virus such as COVID-19. As someone who is recovering or has recovered from COVID-19, your participation may prove key in clinical research and trials. 

Such trials may be categorized as one of the following:

  • Treatment studies: Test new treatments, new combinations of drugs, or new approaches and therapies.
  • Prevention studies: Investigate better approaches to eliminate disease which may include medicines, vaccines, or lifestyle changes, among other things.
  • Diagnostic studies: Evaluate and determine better methods of testing or procedures for identifying a particular disease or condition.
  • Screening studies: Investigate and determine the best way to detect certain diseases or health conditions.
  • Quality of life studies (or supportive care studies): Explore and measure ways to improve the comfort and quality of life of people who have suffered from the disease. 

Carefully conducted clinical research studies are seen as the fastest and safest way to find effective treatments, improve standards of care, and identify methods to improve health care.  Participating in clinical research is essential for the development of new medications and new treatments. Click here for FAQs on the COVID-19 vaccine clinical trials.

Local Clinical Trials and Studies

University of Maryland School of Public Health: Virus Shedding and Face Mask Study

        Currently recruiting:

  • Anyone with COVID-19 who has recent onset of symptoms (a week or less and isolated at home) for virus shedding and face mask testing;
  • Household contacts of someone with COVID-19 infection for contact follow-up testing; or
  • Anyone working or living on or near the UMD College Park campus for a daily survey and weekly testing

For more information about this and other UMD studies about COVID-19 email stopcovid@umd.edu or call 424-246-8358.

University of Maryland School of Medicine: Experimental COVID-19 Vaccine

Johns Hopkins University Research Studies

  • If you have been exposed to COVID-19, but have no symptoms and/or tested negative:

You may be eligible to participate in the CSSC-001 trial. This trial uses convalescent plasma, which comes from a blood donation by people who have fully recovered from the coronavirus disease, COVID-19. The trial will test whether the antibodies in this plasma can help prevent COVID-19 in people who have been exposed to coronavirus, but are not sick.

Please email CovidPlasmaTrial@jhmi.edu to learn more.

  •  If you have tested positive for COVID-19:

You may be eligible to participate in the CSSC-004 trial. This trial uses convalescent plasma, which comes from a blood donation by people who have fully recovered from the coronavirus disease, COVID-19. The trial will test whether the antibodies in this plasma can help prevent severe illness and hospitalization in people who are sick with COVID-19.

Please email CovidPlasmaTrial@jhmi.edu to learn more.